Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 in the page footer, signaling a new version of the page. The study content and visible details appear unchanged.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded new navigation/help sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updated the Interventions/Treatment label. The old 'Intervention / Treatment' heading was removed and the revision tag updated to v3.6.0.SummaryDifference0.4%

- Check25 days agoChange Detected- Displayed Revision: v3.5.5 replaces v3.5.4 in the page header, indicating a frontend version update. - This change is limited to metadata and does not alter the study details presented on the page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision marker was updated from v3.5.3 to v3.5.4, indicating a version update in the page's metadata.SummaryDifference0.0%

- Check67 days agoChange DetectedThis updates the site’s displayed revision/version label for the ClinicalTrials.gov page (from v3.5.2 to v3.5.3) without changing the study content.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.